This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts and esters thereof. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating and preventing atherosclerosis and atherosclerotic disease events.
该发明提供了公式I的
胆固醇吸收
抑制剂,以及其药学上可接受的盐和酯。这些化合物可用于降低血浆
胆固醇水平,尤其是LDL
胆固醇,并用于治疗和预防动脉硬化和动脉粥样硬化疾病事件。